Loading…

Serotonin-induced vascular permeability is mediated by transient receptor potential vanilloid 4 in the airways and upper gastrointestinal tract of mice

Endothelial and epithelial cells form physical barriers that modulate the exchange of fluid and molecules. The integrity of these barriers can be influenced by signaling through G protein-coupled receptors (GPCRs) and ion channels. Serotonin (5-HT) is an important vasoactive mediator of tissue edema...

Full description

Saved in:
Bibliographic Details
Published in:Laboratory investigation 2021-07, Vol.101 (7), p.851
Main Authors: Retamal, Jeffri S, Grace, Megan S, Dill, Larissa K, Ramirez-Garcia, Paulina, Peng, Scott, Gondin, Arisbel B, Bennetts, Felix, Alvi, Sadia, Rajasekhar, Pradeep, Almazi, Juhura G, Carbone, Simona E, Bunnett, Nigel W, Davis, Thomas P, Veldhuis, Nicholas A, Poole, Daniel P, McIntyre, Peter
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endothelial and epithelial cells form physical barriers that modulate the exchange of fluid and molecules. The integrity of these barriers can be influenced by signaling through G protein-coupled receptors (GPCRs) and ion channels. Serotonin (5-HT) is an important vasoactive mediator of tissue edema and inflammation. However, the mechanisms that drive 5-HT-induced plasma extravasation are poorly defined. The Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel is an established enhancer of signaling by GPCRs that promote inflammation and endothelial barrier disruption. Here, we investigated the role of TRPV4 in 5-HT-induced plasma extravasation using pharmacological and genetic approaches. Activation of either TRPV4 or 5-HT receptors promoted significant plasma extravasation in the airway and upper gastrointestinal tract of mice. 5-HT-mediated extravasation was significantly reduced by pharmacological inhibition of the 5-HT receptor subtype, or with antagonism or deletion of TRPV4, consistent with functional interaction between 5-HT receptors and TRPV4. Inhibition of receptors for the neuropeptides substance P (SP) or calcitonin gene-related peptide (CGRP) diminished 5-HT-induced plasma extravasation. Supporting studies assessing treatment of HUVEC with 5-HT, CGRP, or SP was associated with ERK phosphorylation. Exposure to the TRPV4 activator GSK1016790A, but not 5-HT, increased intracellular Ca in these cells. However, 5-HT pre-treatment enhanced GSK1016790A-mediated Ca signaling, consistent with sensitization of TRPV4. The functional interaction was further characterized in HEK293 cells expressing 5-HT to reveal that TRPV4 enhances the duration of 5-HT-evoked Ca signaling through a PLA and PKC-dependent mechanism. In summary, this study demonstrates that TRPV4 contributes to 5-HT -induced plasma extravasation in the airways and upper GI tract, with evidence supporting a mechanism of action involving SP and CGRP release. Serotonin (5-HT) is an important mediator of tissue edema and inflammation. The authors used mouse models and cell-based signaling assays to provide greater understanding of the mechanisms involved. They demonstrate that effects of 5-HT are mediated through the 5-HT receptor and involve activation of the mechanosensitive ion channel TRPV4 and neuropeptide release.
ISSN:1530-0307